Apoptosis of vascular smooth muscle cells (VSMC) in advanced atherosclerotic plaques is an important cause of plaque instability. Oxysterols have been suggested as important inducers of apoptosis in VSMC, but the precise mechanism is still poorly understood. Here we aimed to analyse the role of the soluble adenylyl cyclase (sAC).
Introduction
Numerous studies have confirmed the presence of apoptotic cells in atherosclerotic plaques. 1 Within several cell types, the apoptosis of vascular smooth muscle cells (VSMC) is of significant importance for the stability of advanced, symptomatic plaques. Indeed, symptomatic plaques exhibit increased levels of apoptotic VSMC 2 compared with stable lesions, and the inhibition of VSMC apoptosis stabilizes atherosclerotic plaques in vivo. 3 Within various pro-apoptotic stimuli, oxysterols (oxidized cholesterol derivatives) are of great significance. 4 Several reports suggest that oxysterols are pro-apoptotic in different cell types, including VSMC. 5 Nonetheless, the precise cellular pathways that govern oxysterol-induced VSMC apoptosis still remain to be elucidated. Within several signalling pathways, cAMP/protein kinase A (PKA) signalling plays an essential role in controlling apoptotic processes. Until now the contribution of this pathway was exclusively attributed to the activation of the ß-receptor-coupled transmembrane adenylyl cyclase (tmAC). Apart from tmAC, a second source of cAMP, the type 10 soluble adenylyl cyclase (sAC), has also been demonstrated for mammalian cells. 6 The cytosolic localization of sAC provides both specificity and selectivity by permitting the generation of cAMP in close proximity to intracellular targets. Whether sAC participates in the oxysterol-induced apoptosis of VSMC is unknown. It has been shown that sAC co-localizes with mitochondria. 7, 8 Furthermore, the translocation of sAC from the cytosol to the mitochondria has been demonstrated under extracellular acidosis or anoxia. 8, 9 Because mitochondria play a crucial role in apoptosis, we hypothesized that intracellularly localized sAC may contribute to VSMC apoptosis.
Methods
A more complete version of the methods can be found as Supplementary material online.
Cell isolation and culture
Spontaneously immortalized aortic VSMC were derived from newborn rats (a gift from Peter Jones, University of Southern California, CA, USA). The cells were grown in minimum essential Eagle's medium supplemented with 10% foetal calf serum, 2% tryptose phosphate broth, 50 U/mL penicillin, and 50 mg/mL streptomycin. The foetal calf serum concentration was reduced to 2% 24 h before the experiments. The smooth muscle phenotype was confirmed by the expression of typical SMC markers, i.e. immunocytostaining with antibodies against alpha smooth muscle actin (Sigma-Aldrich), smoothelin (Abcam) and S100 calcium binding protein A4 (S100A4, Abcam).
Treatments
The VSMC were exposed to 25-hydroxycholesterol, dissolved in DMSO (25-OHC, 40 mmol/L, Sigma-Aldrich), or 7-ketocholesterol, dissolved in ethanol (7-KC, 30 mmol/L, Sigma-Aldrich). KH7 (30 mmol/L, Cayman Chemical), N-acetyl-L-cysteine, dissolved in PBS and adjusted to pH 7.4 (NAC, 5 mmol/L, Sigma-Aldrich), Bax inhibitory peptide (V5), dissolved in water (100 mmol/L, Calbiochem), rotenone, dissolved in DMSO (20 mmol/L, Calbiochem), thenoyltrifluoroacetone, dissolved in DMSO (TTFA, 10 mmol/L, Calbiochem) or adenosine 3 ′ ,5 ′ -cyclic monophosphorothioate, Rp-isomer, dissolved in water (Rp-cAMP, 100 mmol/L, BioLog), and N6-benzoyladenosine-3 ′ ,5 ′ -cyclic monophosphate, dissolved in water (6-Bnz-cAMP 100 mmol/L, BioLog) were applied as indicated. The final concentration of DMSO or ethanol in the medium was ,0.1%.
Stable sAC knockdown
The sAC-targeted shRNA and scrambled shRNA expression plasmids were constructed using a pLKO.1-puro vector (Addgene). Pairs of sense and antisense hairpin oligonucleotides were annealed to form the shRNA cassette and subcloned into the EcoRI/AgeI sites of the pLKO.1-puro vector (see Supplementary material online, Methods for oligonucleotide sequences details). Recombinant lentiviral particles were prepared by transfecting HEK293T cells with the appropriate pLKO.1-puro plasmid plus the pCMVDR8.2 and pHIT G plasmids. The cells stably transfected with the shRNA were purified using puromycin selection. The extent of sAC knockdown was determined using western blot analysis with antibodies against sAC.
Stable sAC overexpression
The plasmids for the stable untargeted expression of sAC, i.e. predominantly in the cytosol (cyt-sAC), or mitochondria-targeted sAC (mt-sAC) were kindly provided by Dr Giovanni Manfredi (Weill Medical College of Cornell University, USA). The cloning procedures have been described in detail previously 10 (see Supplementary material online, Methods for detailed protocols).
Statistical analyses
The data are provided as mean + SEM, where mean indicates biological replicate. Comparisons of the means between the groups were performed using a one-way analysis of variance followed by the Holm-Sidak post-hoc test. Statistical significance was accepted when P , 0.05.
Results

sAC inhibition prevents the oxysterol-induced apoptosis of VSMC
To test the effect of oxysterols on cell death, the cells were treated with 25-hydroxycholesterol (40 mmol/L) or 7-ketocholesterol (30 mmol/L), which are two oxidation products of cholesterol found in human atherosclerotic plaques. 11 We found that at these concentrations, the oxysterols produce maximal effects on apoptosis with minimal effects on necrosis. Treatment with oxysterols for 24 h significantly increased the number of apoptotic cells (TUNEL-staining), caspase-3 cleavage, and LDH release ( Figure 1A-C Figure S1 ).
To check whether treatment with oxysterols has some effect on cell phenotype, staining of cells with smoothelin (marker for contractile phenotype) or with S100A4 (marker for secretory phenotype) was performed. We found (see Supplementary material online, Figure S2 ) that control as well as oxysterols-treated cells markedly express both markers. These findings suppose, therefore, that treatment with oxysterols for 18 h in our model does not influence significantly the phenotypes of cells.
To examine the role of sAC in VSMC apoptosis, a treatment with the selective sAC inhibitor KH7 13 was applied. Preliminary tests demonstrated that KH7 dose-dependently reduced the cellular cAMP content with a maximal effect at 30 mmol/L ( Figure 1D ). Treatment with KH7 at this concentration suppressed oxysterol-induced apoptosis and LDH release.
Mitochondria play an essential role in sAC-dependent apoptosis in VSMC
Previous reports emphasize the importance of the extrinsic (death receptor) and the intrinsic (mitochondria) pathways of apoptosis in VSMC. 14, 15 In our model, no activation of the death receptor pathway, as examined by caspase-8 cleavage, or endoplasmic reticulumdependent pathway, as examined by caspase-12 cleavage, could be detected under any experimental condition ( Figure 2A) . In contrast, a marked cleavage of caspase-9 was found during oxysterols treatment, which was prevented by sAC inhibition with KH7 ( Figure 2B ).
To further substantiate the role of sAC in the oxysterol-induced mitochondria-dependent apoptosis of VSMC, sAC knockdown was performed, which reduced the expression of the 50 kDa sAC protein in the VSMC by .85% compared with the scrambled shRNA ( Figure 2C ). Subsequent analyses of apoptosis demonstrated that the oxysterol treatment-induced cytochrome c release and caspase-9 cleavage were prevented by sAC knockdown ( Figure 2D ). Thus, sAC knockdown and its pharmacological inhibition suggest a key role for sAC in the oxysterol-induced activation of the mitochondrial pathway of apoptosis in VSMC.
To determine whether oxysterol treatment influences the activity and/or spatial distribution of sAC, the cellular cAMP content and co-localization of sAC within mitochondria were analysed in control and 25-hydroxycholesterol-treated cells. We found that oxysterol treatment had no effect on the cAMP content (see Supplementary material online, Figure S3A ). Importantly, the difference in cAMP content between the untreated and KH7-treated cells was not affected by the oxysterol treatment. These data suggest that oxysterol treatment do not influence sAC activity. In agreement with this conclusion, no changes in cytosolic Ca 2+ concentration, which is an important trigger of sAC activity, has been found during 24 h treatment with 25-hydroxycholesterol (see Supplementary material online, Figure S3B ). In contrast, 10 h of treatment with 25-hydroxycholesterol led to a marked translocation of cytosolic sAC to the mitochondria (see Supplementary material online, Figure S3C ). Therefore, mitochondrial Type 10 adenylyl cyclase in oxysterols-induced apoptosis translocation rather than sAC activation appears to be the initial step in oxysterol-induced apoptosis.
Analysis of cAMP content in sAC knockdown cells revealed no significant alteration of cAMP compared with scrambled cells (in pmol/mg protein: 9.1 + 1.2 in knockdown vs. 10.6 + 0.7 in scrambled cells), which may be due to several compensatory mechanisms, e.g. increased sAC activity or reduced phosphodiesterase activity in knockdown cells.
Oxysterol treatment-induced ROS release is sAC-dependent and plays a key role in VSMC apoptosis
To investigate the underlying cellular mechanisms of the sACdependent apoptosis of VSMC that is induced by oxysterols, the role of reactive oxygen species (ROS) was examined. Previous reports have emphasized the contribution of ROS in the mechanisms of oxysterol-induced apoptosis in different cell types. 16, 17 A time-course analysis of ROS formation in VSMC revealed a significant increase in ROS levels 6 h after treatment with 25-hydroxycholesterol, which reached a maximal value after 18 h ( Figure 3A) . Subsequent analyses of caspase-9/-3 cleavage demonstrated a similar time course, i.e. beginning after 12 h, while reaching a maximum within 18-24 h. Because ROS are known as a potential trigger of apoptosis, we examined the causal role of ROS in our model. Scavenging ROS by treatment with NAC prevented the oxidation of DCF ( Figure 3B ) and abolished caspase-9/-3 cleavage ( Figure 3C ). Therefore, oxysterol-induced ROS appears to be a key mechanism responsible for apoptosis in our model. We examined whether ROS formation occurred in a sACdependent manner. Suppression of sAC activity either by treatment with KH7 or by knockdown significantly reduced DCF oxidation, and this effect was equal to the scavenging of ROS with NAC ( Figure 3B) .
Treating the cells with 20 mmol/L rotenone, an inhibitor of complex I, or with 10 mmol/L TTFA, an inhibitor of complex II, prevented oxysterol-induced ROS formation ( Figure 3D ). Both inhibitors displayed similar effects to the treatment with ROS scavenger NAC. These findings suggest that mitochondria are the main source of oxysterol-induced ROS generation in our model.
To further support the role of mitochondria in ROS formation, a mitochondria specific dye for superoxide anion MitoSOX was applied. Examination of ROS with this dye revealed a significant increase of ROS production under treatment with 25-hydroxycholesterol ( Figure 3E ).
To prove whether oxysterol treatment may affect the mitochondrial membrane potential, fluorescent dye JC-1 was applied. We found that 24 h treatment with 25-hydroxycholesterol had no effect on JC-1 ratio (68.8 + 3.1 vs. 65.5 + 3.4 in control cells, n ¼ 24). In contrast, treatment with 1 mmol/L FCCP, a mitochondrial uncoupler, significantly reduced JC-1 ratio (17.0 + 1.9, n ¼ 8), i.e. led to mitochondrial depolarization. 
Role of PKA in the sAC-dependent apoptosis of VSMC
Because PKA is an important downstream target for sAC, we analysed the potential contribution of this kinase in oxysterol-induced apoptosis. For this purpose, PKA inhibition with the specific cAMP-binding site inhibitor adenosine 3 ′ ,5 ′ -cyclic monophosphorothioate (Rp-cAMP, 100 mmol/L) was first performed in cells transfected with a scrambled shRNA. Secondly, PKA activation using 100 mmol/L 6-Bnz-cAMP (a cAMP analogue preferentially activating PKA) 18 was applied in sAC knockdown cells. We found that PKA inhibition significantly suppressed oxysterol-induced caspase-3 cleavage and ROS formation in the control cells, which was comparable with the effect of sAC knockdown ( Figure 4) . The beneficial effect of sAC knockdown on apoptosis and ROS formation was completely reversed by treating the knockdown cells with a PKA activator. Therefore, PKA appears to be an essential downstream target for sAC in our model.
3.5 A key role for the Bax protein in the sAC/ PKA-dependent apoptosis of VSMC Increasing evidence suggests an essential role for the pro-apoptotic protein Bax in triggering the mitochondrial pathway of apoptosis. When analysing the role of Bax in our model, we found a pronounced binding of Bax to the mitochondria during oxysterol treatment, which was sAC-dependent ( Figure 5A ). Because PKA is an important downstream target for sAC and may promote mitochondrial Bax binding through Bax phosphorylation at Thr(167), 9 we investigated Bax phosphorylation. Treatment with 25-hydroxycholesterol significantly increased Bax phosphorylation at Thr(167), which was prevented by the inhibition of sAC or PKA ( Figure 5B) . Therefore, Bax phosphorylation/translocation appears to be under the control of the sAC/PKA axis. Analysis of mitochondrial binding of other Bcl-2 family proteins, Bim, Bad, Bcl-xL, and Bcl-2, did not reveal any significant sAC-dependent effect of the treatment with 25-hydroxycholesterol (see Supplementary online material, Figure S4 ).
To examine whether Bax plays a causal role in sAC/PKA signallingdependent mitochondrial ROS formation and, therefore, in apoptosis, the translocation of Bax to the mitochondria was suppressed by treatment with a Bax inhibitory peptide. Treatment with this peptide has been demonstrated to prevent the translocation of Bax to the mitochondria. 10, 19 In our model, application of the Bax inhibitory peptide prevented 25-hydroxycholesterol-induced DCF oxidation ( Figure 5C ). Therefore, Bax appears to be an important causal link between the sAC/PKA axis and mitochondrial ROS formation.
Role of the cytosolic vs. mitochondrial pool of sAC
A previous report demonstrated that sAC is localized in the mitochondrial matrix and controls the activity of the cytochrome chain and ROS formation in a PKA-dependent manner. 10 To examine whether the Type 10 adenylyl cyclase in oxysterols-induced apoptosis intra-mitochondrial pool of sAC contributes to the oxysterol-induced activation of the mitochondrial pathway of apoptosis, a targeted overexpression of the mitochondrial sAC was performed. The effects of oxysterols in these cells were compared with cells overexpressing cytosolic sAC or with cells transfected with the empty vector. Cytosol-or mitochondria-directed sAC overexpression led to increases in the 50 kDa protein of 150 and 180% in the selected clones, respectively ( Figure 6A) . Analysis of apoptosis demonstrated that the oxysterol-induced caspase-9/-3 cleavage and ROS formation were not altered by the mitochondrial overexpression of sAC ( Figure 6B and C) .
In contrast, the cytosolic overexpression of sAC significantly enhanced caspase cleavage compared with the empty vector.
Discussion
Many studies have been performed to understand the signalling pathways controlling oxysterol-induced apoptosis in different cell types. In the present study, the contribution of cAMP-dependent signalling was investigated. Particularly, the role of the intracellularly localized sACderived pool of cAMP was considered. Our recent studies suggest the involvement of sAC in the ischaemic stress-induced apoptosis of coronary endothelial cells and cardiomyocytes. 8, 9 Therefore, in the present study, we focused on the role of this cyclase in oxysterol-induced VSMC apoptosis. For this purpose, treatment with the selective sAC inhibitor KH7 13 or sAC knockdown were applied. Both tools prevented oxysterol-induced apoptosis, demonstrating the key role of sAC. The effects of oxysterols on the activation of apoptotic pathways may differ among cell types. 15,20 -22 Although the contributions of specific apoptotic pathways to oxysterol-induced VSMC death have not yet been comprehensively investigated, several reports emphasize the role of mitochondria. 23 In agreement with these findings, activation of the mitochondrial pathway of apoptosis has been found in our model after oxysterol treatment, whereas the death receptor pathway (caspase-8 cleavage) was not involved. Furthermore, mitochondria seem to be an important target for sAC in our model. Indeed, the prevention of cytochrome c release and caspase-9 cleavage as well as mitochondrial Bax translocation by inhibiting sAC clearly demonstrate that the activation of the mitochondrial pathway of apoptosis is under the control of sAC.
PKA is an important downstream target of cAMP. By applying two different approaches, i.e. (i) PKA inhibition in control cells or (ii) PKA activation in sAC knockdown cells, we determined that PKA plays an essential role in our model. To determine a link between the sAC/ PKA axis and the mitochondrial pathway of apoptosis, we examined Type 10 adenylyl cyclase in oxysterols-induced apoptosis the role of ROS. Evidence demonstrating the involvement of PKA in the ROS production induced by various stresses has accumulated. 24 -26 ROS has also been found to contribute in oxysterol-induced apoptosis. 16, 17 In agreement with these reports, marked ROS production was observed 6 h after treatment with 25-hydroxycholesterol, reaching a maximal value after 18 h. In addition, this ROS production was sACand PKA-dependent, and scavenging the ROS with NAC abolished apoptosis in the VSMC. Moreover, by inhibiting complexes I and II of the mitochondrial electron transport chain, we found that mitochondria are the main source of the ROS induced by oxysterol treatment. Therefore, these findings suggest that ROS is a direct causal link between the sAC/PKA axis and mitochondrial apoptosis. However, how the sAC/PKA axis may control mitochondrial ROS production is still unclear. The mitochondrial electron transport chain is the main source of superoxide anion formation due to electron leak. 27 The activity of the electron transport chain is regulated by PKA-dependent phosphorylation at several sites and may significantly contribute to ROS production. 28 For example, inactivation of the cytochrome c oxidase due to PKA-dependent hyperphosphorylation of its subunits markedly increases ROS production. 29 Because the functional sAC/PKA axis is located in the mitochondrial matrix, 10, 30 we proved whether the intramitochondrial pool of sAC may be responsible for the observed ROS formation and apoptosis in our model. By applying the targeted overexpression of sAC in mitochondria, we found that this pool of sAC does not play a role in our model. In contrast, overexpression of cytosolic sAC significantly increased ROS formation and apoptosis under oxysterols treatment. Therefore, the cytosolic rather than the intra-mitochondrial pool of sAC controls oxysterol-induced apoptosis in VSMC. In contrast to our finding, previous reports of Acin-Perez et al. 10, 30 suggest that intra-mitochondrial sAC/PKA signalling interferes with the mitochondrial ROS production and that inhibition of sAC or PKA slightly but significantly increases ROS production. This discrepancy may be due to differences in models, i.e. control conditions in AcinPerez's studies compared with apoptosis induction in our study. Furthermore, the extracellular rather than the intra-mitochondrial pool of sAC is involved in the ROS generation in our study ( Figure 6C) . Finally, the effect of PKA-activity modulation in the above study led to the alteration of ROS production by 30-40%, which is in range of normal regulation of the mitochondrial biogenesis by ROS as a second messenger. 31 In contrast, in the present report, oxysterol treatment led to the rise of ROS production by several folds.
To understand more about the mechanisms involved in the control of oxysterol-induced apoptosis by the cytosolic pool of sAC, analyses of sAC activity and its spatial distribution were performed. Although no effect on sAC-specific cAMP production was found (see Supplementary material online, Figure S3A ), a pronounced translocation of cytosolic sAC to the mitochondria was observed. These findings suppose that the translocation of sAC from the cytosol to the mitochondria may lead to a selective activation of PKA localized within mitochondrial microdomains. Several reports have emphasized that PKA signalling is controlled by PKA-anchoring proteins, which tether PKA pools and localize them at discrete subcellular microdomains in close proximity to kinase-specific downstream substrates. 32, 33 In particular, the compartmentalization of PKA within mitochondrial microdomains 34, 35 and its contribution to mitochondrial apoptosis 36, 37 have been demonstrated.
In the present study, to identify the possible PKA-specific downstream substrate involved in sAC/PKA-dependent apoptosis, the role of the Bcl-2 family proteins was investigated. Several reports suggest a participation for some of the proteins within this group in the PKAdependent control of mitochondrial apoptosis by direct phosphorylation of these proteins. 9,38 -41 Within numerous members of this family, Bax appears to be a key protein, contributing to the activation of the mitochondrial pathway of apoptosis. Bax phosphorylation at serine/threonine residues is an essential mechanism regulating Bax activity and its binding to the outer mitochondrial membrane. 40 PKA has been demonstrated to play a substantial role in the regulation of Bax activity. 40 Recent reports have demonstrated that the phosphorylation of Bax at Thr(167) by JNK, p38 or PKA promotes the translocation of Bax to the mitochondria. 9, 41 In agreement with these reports, Bax translocation to the mitochondria was observed during oxysterol treatment in our study, which was prevented by inhibiting either sAC or PKA. Moreover, oxysterol treatment led to Bax phosphorylation at Thr(167) in a sAC-and PKA-dependent manner. A direct suppression of mitochondrial Bax binding due to treatment with a specific Bax-inhibiting peptide prevented oxysterol-induced ROS formation. Altogether, these findings suggest that oxysterol-induced phosphorylation and the translocation of Bax to the mitochondria in VSMC is dependent on sAC/PKA activity and is a key event in triggering the mitochondrial pathway of apoptosis.
In conclusion, the present study describes a novel signalling pathway controlling the mitochondrial pathway of apoptosis induced by oxysterol treatment in VSMC. The underlying cellular mechanisms consist of the mitochondrial translocation of cytosolic sAC followed by the PKA-dependent phosphorylation and mitochondrial translocation of Bax. These events result in mitochondrial ROS formation and cytochrome c release. While the cytosolic pool of sAC significantly contributes to oxysterol-induced apoptosis, intra-mitochondrial sAC appears to play no role in this type of apoptosis. Strategies directed towards suppressing cytosolic sAC activity/translocation may contribute to the stabilization of advanced atherosclerotic plaques.
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